NATR: Nature's Sunshine Products, Inc. Stock

by  •  • Comments Off on NATR: Nature's Sunshine Products, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 218.47
Enterprise Value ($M) 139.45
Book Value ($M) 160.99
Book Value / Share 8.71
Price / Book 1.36
NCAV ($M) 80.72
NCAV / Share 4.37
Price / NCAV 2.71

Profitability (mra)
Return on Invested Capital (ROIC) 0.04
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.05

Liquidity (mrq)
Quick Ratio 1.54
Current Ratio 2.44

Balance Sheet (mrq) ($M)
Current Assets 160.58
Assets 240.85
Liabilities 79.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 454.36
Operating Income 20.09
Net Income 7.70
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 25.30
Cash from Investing -10.97
Cash from Financing -9.90

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-21 7,776 31,320 24.83
2025-04-17 4,819 35,514 13.57
2025-04-16 7,183 43,994 16.33

(click for more detail)

Similar Companies
MTVA – MetaVia Inc. MYNZ – Mainz Biomed N.V.
NAGE – Niagen Bioscience, Inc. NERV – Minerva Neurosciences, Inc.
NKTR – Nektar Therapeutics


Financial data and stock pages provided by
Fintel.io